New Treatment for Vitiligo - Skin Transplant

New Treatment for Vitiligo - Skin Transplant - This is the first study of its kind in the United States, showed that surgery for skin grafts is safe and effective for the treatment of vitiligo. Researchers followed 23 patients for up to six months after surgery and found that the treated surface again, on average, 52 percent of their natural skin color. In eight patients with a certain type of vitiligo, the treated area, on average, once 74 percent of its natural color.

The transaction is consistent with cells of the skin normally pigmented areas of the body removed and their transfer to the damaged area of skin. It is performed under local anesthesia.

vitiligo skin transplant

"This will give patients hope vitiligo, said Iltefat Hamzavi, MD, a staff physician at Henry Ford Senior, Department of Dermatology and the lead author of the study and principal investigator." Our results for the study were achieved obvious importance to our patients. "

The study will be presented Tuesday, March 9, at the 68th Annual Meeting of the American Academy of Dermatology meeting in Miami.

While early results are preliminary and the case is still at an experimental stage, this operation as part of their treatment portfolio offering this fall. He said that in some patients, surgery is more effective than standard treatments, including drug therapy and topical.

"Patients with vitiligo and color on one side of the body and in an area of the body can benefit most from this procedure, says Dr. Hamzavi.

Vitiligo is a skin disease, skin color and lose to develop white spots, which vary in size and location factors. It affects about 1 in 200 people in the United States and is more sensitive in people with dark skin.

Vitiligo occurs when cells called melanocytes are killed by the body's immune system, so that the surface of the skin become white, not because they are the most pigment cells. Although there is no cure, vitiligo can be treated with light therapy, topical creams and medications have resulted.

The operation is performed as is known melanocyte-keratinocyte transplantation or MKTP and Europe, Asia and the Middle East follows the same procedure that develops pioneering MKTP Mulekar Sanjeev, MD, National Center of vitiligo in Saudi Arabia.

Studies show of 32 patients (18 men, 14 women) were operated between 18 and 60 There were a total of 40 MKTP procedures were performed and analyzed the results of 29 investigators from them. The procedure took 30 minutes to two hours, and patients go home the same day.

Of the 32 patients the operation was followed by 23 for a maximum of six months after the operation. Eighteen patients were treated, four patients received two and one patient received three. The ethnicity of patients was Caucasian, South Asian, African American and Hispanic.

While MKTP, melanocytes are cells that produce the pigment of the skin, eyes and hair, collected from an area of healthy skin and to separate a mixture of skin. This mixture is then applied to the treatment area, and with a bio-adhesive specially developed cover dressing.

The treated areas, including hands, arms, legs, feet, face and abdomen. The average size of area treated during each procedure, which covers an area of 46 cm2, or about the size of a credit card.

copyright 2010 Effective Vitiligo Treatment

Saturday, March 13, 2010

New Treatment for Vitiligo - Skin Transplant

New Treatment for Vitiligo - Skin Transplant - This is the first study of its kind in the United States, showed that surgery for skin grafts is safe and effective for the treatment of vitiligo. Researchers followed 23 patients for up to six months after surgery and found that the treated surface again, on average, 52 percent of their natural skin color. In eight patients with a certain type of vitiligo, the treated area, on average, once 74 percent of its natural color.

The transaction is consistent with cells of the skin normally pigmented areas of the body removed and their transfer to the damaged area of skin. It is performed under local anesthesia.

vitiligo skin transplant

"This will give patients hope vitiligo, said Iltefat Hamzavi, MD, a staff physician at Henry Ford Senior, Department of Dermatology and the lead author of the study and principal investigator." Our results for the study were achieved obvious importance to our patients. "

The study will be presented Tuesday, March 9, at the 68th Annual Meeting of the American Academy of Dermatology meeting in Miami.

While early results are preliminary and the case is still at an experimental stage, this operation as part of their treatment portfolio offering this fall. He said that in some patients, surgery is more effective than standard treatments, including drug therapy and topical.

"Patients with vitiligo and color on one side of the body and in an area of the body can benefit most from this procedure, says Dr. Hamzavi.

Vitiligo is a skin disease, skin color and lose to develop white spots, which vary in size and location factors. It affects about 1 in 200 people in the United States and is more sensitive in people with dark skin.

Vitiligo occurs when cells called melanocytes are killed by the body's immune system, so that the surface of the skin become white, not because they are the most pigment cells. Although there is no cure, vitiligo can be treated with light therapy, topical creams and medications have resulted.

The operation is performed as is known melanocyte-keratinocyte transplantation or MKTP and Europe, Asia and the Middle East follows the same procedure that develops pioneering MKTP Mulekar Sanjeev, MD, National Center of vitiligo in Saudi Arabia.

Studies show of 32 patients (18 men, 14 women) were operated between 18 and 60 There were a total of 40 MKTP procedures were performed and analyzed the results of 29 investigators from them. The procedure took 30 minutes to two hours, and patients go home the same day.

Of the 32 patients the operation was followed by 23 for a maximum of six months after the operation. Eighteen patients were treated, four patients received two and one patient received three. The ethnicity of patients was Caucasian, South Asian, African American and Hispanic.

While MKTP, melanocytes are cells that produce the pigment of the skin, eyes and hair, collected from an area of healthy skin and to separate a mixture of skin. This mixture is then applied to the treatment area, and with a bio-adhesive specially developed cover dressing.

The treated areas, including hands, arms, legs, feet, face and abdomen. The average size of area treated during each procedure, which covers an area of 46 cm2, or about the size of a credit card.

copyright 2010 Effective Vitiligo Treatment